Humana director Paul John Smith reports no common shares

Q: What does Paul John Smith’s Form 3 for HUMANA INC (HUM) report?

The Form 3 shows that director Paul John Smith reports 0.0000 shares of Humana Common held directly. It is an initial statement of beneficial ownership and lists one holding entry with no reported purchases, sales, gifts, or derivative positions.

Q: Does Paul John Smith own any Humana Common shares according to this Form 3 for HUM?

According to the Form 3, Paul John Smith reports 0.0000 shares of Humana Common held directly. This establishes a baseline of no reported direct equity position in Humana stock at the time covered, with no concurrent transactions disclosed.

Q: Are any stock transactions reported for HUM in Paul John Smith’s Form 3?

No stock transactions are reported. The summary data show zero buy and sell transactions, with one holding entry only. There are no exercises, gifts, restructurings, or derivative trades disclosed for Humana securities in this initial ownership statement.

Q: Does the Form 3 for HUM mention any derivatives or options held by Paul John Smith?

The data indicate no derivative positions reported for Paul John Smith. The derivative summary is empty and transaction counts for derivative exercises or related activity are zero, so only a single non-derivative holding line with zero shares is disclosed.

Q: How many holdings entries are disclosed in Paul John Smith’s Form 3 for HUMANA INC?

The transaction summary identifies one holding entry for Humana Common. That entry reports 0.0000 shares directly owned after the reported date, and there are no additional holdings or derivative lines included in this initial ownership disclosure.

Paul John Smith, a director of Humana Inc (HUM), filed an initial statement of beneficial ownership that reports 0.0000 shares of Humana Common held directly following the reported date.

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Paul John Smith, a director of Humana Inc (HUM), filed an initial statement of beneficial ownership that reports 0.0000 shares of Humana Common held directly following the reported date. The disclosure shows one holding entry and no buy, sell, gift, or derivative transactions.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Smith Paul John

Role Director

Type	Security	Shares	Price	Value
holding	Humana Common	--	--	--

Holdings After Transaction: Humana Common — 0 shares (Direct)

Key Figures

Reported Humana Common holdings: 0.0000 shares Holding entries reported: 1 Buy transactions: 0

3 metrics

Reported Humana Common holdings 0.0000 shares Total Humana Common shares reported as directly owned following the event

Holding entries reported 1 Number of non-transactional holding rows disclosed in the report

Buy transactions 0 Buy transactions counted in the transaction summary

Key Terms

Humana Common, Rule 10b5-1, direct_or_indirect

3 terms

Humana Common financial

"Security title reported as Humana Common for the holding entry"

Rule 10b5-1 regulatory

"aff_10b5_one field reflects Rule 10b5-1 trading plan status"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

direct_or_indirect financial

"Field indicating whether reported ownership is direct_or_indirect (D or I)"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Paul John Smith’s Form 3 for HUMANA INC (HUM) report?

The Form 3 shows that director Paul John Smith reports 0.0000 shares of Humana Common held directly. It is an initial statement of beneficial ownership and lists one holding entry with no reported purchases, sales, gifts, or derivative positions.

Does Paul John Smith own any Humana Common shares according to this Form 3 for HUM?

According to the Form 3, Paul John Smith reports 0.0000 shares of Humana Common held directly. This establishes a baseline of no reported direct equity position in Humana stock at the time covered, with no concurrent transactions disclosed.

What is Paul John Smith’s role at HUMANA INC in this ownership report?

In this ownership report, Paul John Smith is identified as a director of HUMANA INC. The Form 3 indicates his insider status as a board member while simultaneously showing no directly owned Humana Common shares as of the reported event date.

Are any stock transactions reported for HUM in Paul John Smith’s Form 3?

No stock transactions are reported. The summary data show zero buy and sell transactions, with one holding entry only. There are no exercises, gifts, restructurings, or derivative trades disclosed for Humana securities in this initial ownership statement.

Does the Form 3 for HUM mention any derivatives or options held by Paul John Smith?

The data indicate no derivative positions reported for Paul John Smith. The derivative summary is empty and transaction counts for derivative exercises or related activity are zero, so only a single non-derivative holding line with zero shares is disclosed.

How many holdings entries are disclosed in Paul John Smith’s Form 3 for HUMANA INC?

The transaction summary identifies one holding entry for Humana Common. That entry reports 0.0000 shares directly owned after the reported date, and there are no additional holdings or derivative lines included in this initial ownership disclosure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 07/29/2026 - 03:07 PM EDT

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Smith Paul John

(Last)

(First)

(Middle)

HUMANA INC.

101 E. MAIN STREET

(Street)

LOUISVILLE

KENTUCKY

40202

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
07/28/2026

3. Issuer Name and Ticker or Trading Symbol
HUMANA INC [ HUM ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Humana Common	0	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)

Explanation of Responses:

	John P. Smith	07/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR